Loading...
The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies
Chronic lymphocytic leukemia (CLL) is an indolent but incurable disease. Despite the improvement of the available therapies, the management of heavily-treated CLL patients represents a challenge for modern practitioners. Ofatumumab is a second-generation, fully human anti-CD20 monoclonal antibody th...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3262337/ https://ncbi.nlm.nih.gov/pubmed/22282677 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|